Union Korea Pharm Co., Ltd. (KOSDAQ:080720)

South Korea · Delayed Price · Currency is KRW

8,175.00

-930.00 (-10.21%)

At close: Oct 11, 2024

Union Korea Pharm Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	25,454	36,378	51,280	63,169	61,293	48,304
Revenue Growth	-40.07%	-29.06%	-18.82%	3.06%	26.89%	-4.12%
Gross Profit	2,486	7,759	14,124	20,781	23,917	15,150
Operating Income	-21,472	-23,326	-18,654	-14,682	1,271	-10,615
Net Income	-24,302	-30,820	-20,916	-18,156	-932.02	-11,109
Earnings Per Share	-4721.34	-12789.27	-8682.00	-7543.35	-378.93	-4290.00
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
South Korea	24,707	35,679	48,260	60,910	58,955	46,551
Overseas	747.45	699.62	3,020	2,259	2,338	1,752
Total	25,454	36,378	51,280	63,169	61,293	48,304

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	37,432	6,581	5,761	7,181	7,524	21,120
Total Debt	5,211	21,433	23,993	39,349	37,125	35,867
Net Cash (Debt)	32,222	-14,853	-18,232	-32,169	-29,601	-14,747
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	6259.89	-6163.39	-7566.93	-13365.07	-12034.97	-5693.15

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-1,564	-1,134	420.21	1,362	-5,063	1,915
Capital Expenditures	-78.57	-95.74	-949.44	-2,263	-3,366	-7,168
Free Cash Flow	-1,643	-1,230	-529.23	-901.15	-8,429	-5,254
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	9.77%	21.33%	27.54%	32.90%	39.02%	31.36%
Operating Margin	-84.35%	-64.12%	-36.38%	-23.24%	2.07%	-21.98%
Pretax Margin	-83.64%	-76.44%	-37.00%	-22.80%	1.54%	-29.97%
Profit Margin	-95.47%	-84.72%	-40.79%	-28.74%	-1.52%	-23.00%
FCF Margin	-6.45%	-3.38%	-1.03%	-1.43%	-13.75%	-10.88%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	0.77	0.54	0.30	0.57	0.84	1.62